Search
Showing results for "preterm birth lungs"
ORIGINS Study publishes protocol
Embracing the Mind won the News & Media category at the WA Mental Health Awards
Nanoparticles are being developed for diverse biomedical applications, but there is concern about potential to promote inflammation, particularly in the lungs.
Current NICE 2015 guidelines for bronchiolitis state that the use of HFNC is becoming widespread without demonstration of additional efficacy.
Key barriers to effective management of chronic wet cough are limited training in chronic wet cough management combined with competing complexities
This manuscript will give a brief overview of clinical trial design including the strengths and limitations of various approaches
Aspergillus species and P. aeruginosa are commonly present in the lower airways from infancy
Structural changes identified on CT scans in primary ciliary dyskinesia are not identical to those previously described in cystic fibrosis patients
This Research Note has explored the strengths, risks and potential complexity of adaptive trials
Antisense oligonucleotides are an emerging therapeutic option to treat diseases with known genetic origin. In the age of personalised medicines, antisense oligonucleotides can sometimes be designed to target and bypass or overcome a patient's genetic mutation, in particular those lesions that compromise normal pre-mRNA processing. Antisense oligonucleotides can alter gene expression through a variety of mechanisms as determined by the chemistry and antisense oligomer design.